U.S. Markets close in 3 hrs, 1 min
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,177.14 | 153.72 | 1.53% |
| NASDAQ | 2,143.64 | 31.20 | 1.48% |
| S&P 500 | 1,086.68 | 17.38 | 1.63% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -1.79 | Current P/E Ratio: | -5.37989 |
|---|---|---|---|
| Last Quarter's Earnings: | 0.29 | Current Quarter Estimate: | 0.234 |
| Last Fiscal Year Earnings: | 1.24 | Next Fiscal Year Estimate: | 1.024 |
| Analyst Consensus: | Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 02/22/2010 * | 18:00 | Q4 2009 King Pharmaceuticals Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/05/2009 | Q3 2009 King Pharmaceuticals Earnings Conference Call | — | Download($) |
| 11/05/2009 | Q3 2009 King Pharmaceuticals Earnings Release | — | — |
| 09/22/2009 | King Pharmaceuticals at UBS Global Life Sciences Conference | — | Download($) |
| 08/06/2009 | Q2 2009 King Pharmaceuticals Earnings Conference Call | — | Download($) |
| 08/06/2009 | Q2 2009 King Pharmaceuticals Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts